Interestingly, carbonic anhydrase IX (CaIX), a robust marker of hypoxic tumours [27], is expressed in 23% of all MBs and is associated with poor prognosis [28], suggesting that tumour hypoxia impacts on MB progression and/or management. Here, CA9 is linked to neoplasm.